Collectively, these results link pluripotency factor signaling and the enhanced cell survival of MaCSCs, supporting roles of KLF4-miR-206 signaling for breast tumor cell survival, chemoresistance, and tumor initiation through the repression of PDCD4 and CX43 (Figure 7c). The gene discussed is KLF4; the disease is breast neoplasm.